Australia markets closed

Purple Biotech Ltd (1YI1.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
0.3960-0.0320 (-7.48%)
As of 08:05AM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-18,764
-19,880
-21,668
-18,384
-27,999
-
Depreciation & amortisation
199
197
201
231
235
-
Stock-based compensation
1,389
1,875
2,412
2,082
2,645
-
Change in working capital
1,084
274
3,255
744
-3,438
-
Accounts receivable
-
-
313
-316
-492
1,555
Accounts payable
1,038
1,334
799
399
-2,355
-
Other working capital
-18,943
-19,928
-16,963
-15,366
-12,248
-
Other non-cash items
-2,760
-2,294
-843
-108
15,462
-
Net cash provided by operating activities
-18,943
-19,925
-16,735
-15,251
-12,092
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-3
-228
-115
-156
-
Acquisitions, net
0
-3,549
0
0
-
0
Purchases of investments
-
-
-
0
-49,619
-2,100
Sales/maturities of investments
1,511
16,678
19,818
13,162
-
1,511
Other investing activities
-
-
-
-
1
-
Net cash used for investing activities
1,590
13,881
19,914
13,406
-49,595
-
Cash flows from financing activities
Debt repayment
-171
-168
-165
-153
-179
-
Common stock issued
1,542
1,563
1,498
564
27,925
-
Dividends paid
0
0
0
0
0
-
Other financing activities
-865
-890
-152
-24
-5,355
-
Net cash used provided by (used for) financing activities
5,453
5,449
1,114
1,512
68,488
-
Net change in cash
-11,900
-595
4,293
-333
6,801
-
Cash at beginning of period
21,883
15,030
10,890
11,247
4,385
-
Cash at end of period
9,983
14,489
15,030
10,890
11,247
-
Free cash flow
Operating cash flow
-18,943
-19,925
-16,735
-15,251
-12,092
-
Capital expenditure
-
-3
-228
-115
-156
-
Free cash flow
-18,943
-19,928
-16,963
-15,366
-12,248
-